Company
SpectraWAVE
Shaping the Future of Coronary Care
- Status
- Acquiredas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Bedford, MA, United States
- Employees
- With 50+ talented employeesSource (opens in a new tab)
- Customers
- clinicians
- Legal name
- SpectraWAVE
- spectrawave.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
SpectraWAVE is transforming coronary care with innovative imaging and physiology technologies that empower clinicians to deliver precise, personalized treatment for patients in the cath lab.
Funding snapshot
- Total raised
- $66.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $50.3M2024-09-04
Funding rounds
- Round, 2024
- $50.3M2024-09-04, SEC form D sold, 33 investors
- Round, 2019
- $16.4M2019-05-13, SEC form D sold, 19 investors
About the company
- Status notes
- Philips Agrees To Acquire SpectraWAVE Inc., Advancing Next-Generation Coronary Intravascular Imaging And Physiological Assessment With AI
Products
- Hardware
- HyperVue Imaging System
- Other
- X1-FFR
Exit
- Acquisition
- 2026-06-05
Loading relationship preview